Magnetic Resonant Spectroscopy and Spectroscopic Imaging: A Review of Basic Principles and Recent Achievements in Oncology

Journal of Computational Methods in Sciences and Engineering

Volumn 3, Issue 4, 2003, Pages 505-533

  Belkić, Karen ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Biomedical Imaging; Magnetic Resonance Spectroscopic Imaging; Magnetic Resonance Spectroscopy; Oncology

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; DISEASES; IONIZING RADIATION; MAGNETIC RESONANCE SPECTROSCOPY; MAGNETISM; MEDICAL IMAGING; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONCOLOGY; RADIOTHERAPY; RESONANCE; SPECTROSCOPY; TUMORS;

BIOMEDICAL IMAGING; COMPUTATIONAL ASPECTS; MAGNETIC RESONANCE SPECTROSCOPIC IMAGING; MAGNETIC RESONANCE SPECTROSCOPIES (MRS); NUCLEAR MAGNETIC RESONANCE TECHNIQUES; SPECTROSCOPIC IMAGING; SPECTROSCOPIC INFORMATION; TIMELY IDENTIFICATION;

NUCLEAR MAGNETIC RESONANCE;

EID: 30544439522     PISSN: 14727978     EISSN: None     Source Type: Journal    
DOI: 10.3233/JCM-2003-3403     Document Type: Review

References (81)

1. J. Tepper, Form and function: The integration of physics and biology, Int. J. Radiation Oncology Biol. Phys. 47, 547-548 (2000).
2. National Cancer Institute, Development of Novel Imaging Technologies (Phased Innovation Award), 2000 (http://www.health.gov/healthypeople/).
3. P.G. Kluetz, C.C. Meltzer, V.L. Villemagne et al, Combined PET/CT imaging in oncology. Impact on patient management, Clin. Positron Imaging 3, 223-230 (2000).
4. L.P. Adler, G. Bakale, Positron emission tomography imaging, in: I. Khalkhali, J.C. Maublant, S.J. Goldsmith, Nuclear oncology; Diagnosis and therapy Lippincott Williams & Wilkins, Philadelphia, 2001, p. 289-295.
5. R. Hustinx, F. Benard, A. Alavi, Whole-body FDG-PET imaging in the management of patients with cancer, Seminars in Nuclear Medicine 32, 35-46 (2002).
6. th Edition, Lippincott Williams & Wilkins, Philadelphia, 2001, p. 669-679.
7. S.J. Vaidya, G.S. Payne, M.O. Leach, C.R. Pinkerton, Potential role of magnetic resonance spectroscopy in assessment of tumour response in childhood cancer, Eur. J. Cancer 39, 728-735 (2003).
8. P.A. Bottomley, The trouble with spectroscopy papers, Journal of Magnetic Resonance Imaging 2, 1-8 (1992)
9. P. Fleckenstein, J. Tranum-Jensen, Anatomy in Diagnostic Imaging, Blackwell, Copenhagen, 2001.
10. D. Spielman, In vivo proton MR spectroscopy: basic principles and clinical applications, Section for Magnetic Resonance Technologists Educational Seminars 3, 19-37 (2000).
11. H. C. Charles, The whole body NMR Spectroscopy examination, Section for Magnetic Resonance Technologists Educational Seminars 3, 5-18 (2000).
12. D. J. Drost, Proton magnetic resonance spectroscopy in the brain: Report of AAPM MR Task Group #9, Med. Phys. 29, 2177-219 (2002).
13. I. Rabi, Z.R. Zacharias, S. Millman, P. Kusch, A new method of measuring nuclear magnetic moment, Phys. Rev. 72, 318 (1938).
14. R. Damadian, Tumor detection by nuclear magnetic resonance, Science 171, 1151-1153 (1971).
15. K. Belkić, Why Quantitative Biomedical Spectroscopic Imaging through Magnetic Resonance in Oncology Needs a Complement to the Conventional Fourier-Based Signal Processing, J. Comp. Meth. Sci. Eng. 3, 535-561 (2003).
16. Dž. Belkić, Exact analytical expressions for any Lorentzian spectrum in the fast Padé transform (FPT), J. Comp. Meth. Sci. Eng. 3, 109-186 (2003).
17. Dž. Belkić, Strikingly stable convergence of the fast Padé transform: applications to magnetic resonance spectroscopy (MRS), J. Comp. Meth. Sci. Eng. 3, 299-382 (2003).
18. 1H MR spectroscopy for clinical use, Prog. Nucl. Magn. Reson. Spectroscopy 31, 155-195 (1997).
19. B. Vikhoff-Baaz, In vivo MRS and MRSI: Performance analysis, measurement considerations and evaluation of metabolite concentration images, Göteborg University, Doctoral Dissertation, 2000.
20. 1H MR spectroscopy outside the brain, Magnetic Resonance Materials in Physics, Biology and Medicine 15 (Suppl.), 2 (2002).
21. 1H MRS of breast lesions, Magn. Reson. Med. 48, 215-222 (2002).
22. R. Katz-Brull, P.T. Lavin, R.E. Lenkinski, Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions, J. Natl. Cancer Inst. 94, 1197-1203 (2002).
23. P.C. Lauterbur, Image formation by induced local interactions: Examples employing nuclear magnetic resonance, Nature 242, 190-191 (1973).
24. P. Mansfield, I.L. Pykett, P.G. Morris, Human whole body line-scan imaging by NMR, Br. J. Radiol. 51, 921-922 (1978).
25. Dž. Belkić, Fast Padé transform for magnetic resonance imaging and computerized tomography, Nuclear Instruments and Methods in Physics Research A 471, 165-169 (2001).
26. D. C. Williamson, N.A. Thacker, S.R. Williams, Improved resolution metabolite maps from multi-echo chemical shift imaging data, 20th Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Rotterdam, The Netherlands, 2003.
27. G.J. Beers, J.L. Phillips, F.S. Prato, I. Nair, Biological effects of low-level electromagnetic fields: current issues and controversies, Magn. Reson. Imaging Clin. N. Am. 6, 749-774 (1998).
28. J. F. Schenck, Safety of strong, static magnetic fields, J. Magn. Reson. Imaging 12, 2-19 (2000).
29. S. Ahmed, F.G. Shellock, Magnetic resonance imaging safety: implications for cardiovascular patients, J. Cardiovasc. Magn. Reson. 3, 171-182 (2001).
30. D.S. Bhachu, E. Kanal, Implantable pulse generators (pacemakers) and electrodes: safety in the magnetic resonance imaging scanner environment, J. Magn. Reson. Imaging 12, 201-204 (2000).
31. B. Condon, D.M. Hadley, Potential MR hazard to patients with metallic heart vales: the Lenz effect, J. Magn. Reson. Imaging, 12, 171-176 (2000).
32. D. Pruefer, P. Kalden, W. Schreiber et al, In vitro investigation of prosthetic heart valves in magnetic resonance imaging: evaluation of potential hazards, J. Heart Valve Dis. 10, 410-414 (2001).
33. Editorial Comments: The safe use of equipment in the magnetic resonance environment, Health Devices, 30 421-444 (2001).
34. B. Condon, D.M. Hadley, R. Hodgson, The ferromagnetic pillow: a potential MR hazard not detectable by a hand-held magnet, Br. J. Radiol. 74, 847-851 (2001).
35. M.F. Dempsey, B. Condon, Thermal injuries associate with MRI, Clin. Radiol. 56, 457-465 (2001).
36. R.R. Price, The AAPM/RSNA physics tutorial for residents: MR imaging safety considerations, Radiographics 19, 1641-1651 (1999).
37. J.R. Gill, S.F. Ely, Z. Hua, Environmental gas displacement: three accidental deaths in the workplace, Am. J. Forensic Med. Pathol. 23, 26-30 (2002).
38. R.H. Goh, S. Somers, E. Jurriaans, J. Yu, Magnetic resonance imaging. Application to family practice, Can. Fam. Physician 45, 2118-2132 (1999).
39. I. Garcia-Bolao, V. Albaladejo, A. Benito et al., Magnetic resonance imaging in a patient with a dual-chamber pacemaker, Acta Cardiol. 53, 33-35 (1998).
40. A. Geppert, F. Rauscha, Pacemaker dysfunction in clinical practice, Wien Klin. Wochenschr. 113, 15-26 (2001).
41. P. Kwok, A. Waldeck, J. Strutz, How do metallic middle ear implants behave in the MRI? Laryngorhinootologie 82, 13-18 (2003).
42. C. Teissl, C. Kremser, E.S. Hochmair, I.J. Hochmair-Dosoyer, Magnetic resonance imaging and cochlear implants: compatibility and safety aspects, J. Magn. Reson. Imaging, 9, 26-38 (1999).
43. P. Mansfield, R.M. Bowley, B.M. Haywood, Controlled E-field gradient coils, Magnetic Resonance Materials in Physics, Biology and Medicine 16, 113-120 (2003)
44. D. Vigneron, A. Bollen, M. McDermott et al, Three-dimensional magnetic resonance spectroscopic imaging of histologically confirmed brain tumors, Magnetic Resonance Imaging 19, 89-101 (2001).
45. V. Govindaraju, K. Young, A.A. Maudsley, Proton NMR chemical shifts and coupling constants for brain metabolites, NMR Biomed. 13, 129-153 (2000).
46. M. Murphy, D.J.O. McIntyre, H. Marsh, B.A. Bell, J.R. Griffiths, Two-dimensional chemical shift imaging (2D-CSI) for surveillance of low grade astrocytomas, Magnetic Resonance Materials in Physics, Biology and Medicine 15 (Suppl.), 146-147 (2002).
47. E.D. Gotsis, K. Fountas, E. Kapsalaki, P. Toulas, G. Peristeris, N. Papadakis, In Vivo proton MR spectroscopy: The diagnostic possibilities of lipid resonances in brain tumors, Anticancer Research, 16, 1565-1568 (1996).
48. L. Kwock, J.K. Smith, M. Castillo et al, Clinical applications of proton MR spectroscopy in oncology, Technol. Cancer Res. Treat. 1, 17-28 (2002).
49. E.T.S. Smith, K. Tyler, K. Das, Can 2 minute duration single voxel proton MR Spectroscopy be used successfully in routine clinical neuroradiological practice to grade cerebral gliomas? Magnetic Resonance Materials in Physics, Biology and Medicine 15 (Suppl.), 146 (2002).
50. I.M. Burtscher, Proton magnetic resonance spectroscopy in brain tumors. Clinical applications. Lund University, Unpublished Doctoral Dissertation, 1999.
51. I.M. Burtscher, G. Skagerberg, B. Geijer et al, Proton MR spectroscopy and preoperative diagnostic accuracy: An evaluation of patients with intracranial mass lesions who underwent stereotactic biopsy, Am. J. Neuroradiol. 21, 84-93 (2000).
52. E. Salminen, A. Hogg, D. Binns et al, Investigations with FDG-PET scanning in prostate cancer show limed value for clinical practice, Acta Oncol. 41, 425-429 (2002).
53. J. Scheidler, H. Hricak, D.B. Vigneron et al, Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging - Clinicopathologic study, Radiology 213, 473-480, (1999).
54. K.K. Yu, J. Scheidler, H. Hricak et al, Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging, Radiology 213, 481-488 (1999).
55. M.G. Swanson, D.B. Vigneron, T-K.C. Tran et al, Single-voxel over-sampled J-resolved spectroscopy of in vivo human prostate tissue, Magn. Reson. Medicine 45, 973-980 (2001).
56. E. Prats, Symposium of breast imaging, Nucl. Med. Commun. 23, 607-608 (2002).
57. M.O. Leach, the MARIBS Advisory Group, The UK National study of magnetic resonance imaging as a method of screening for breast cancer, (MARIBS), J. Exp. Clin. Cancer Res. 21 (Suppl. 3), 107-114 (2002).
58. K.M. Cecil, M.D. Schnall, E.S. Siegelman, R.E Lenkinski, The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy, Breast Cancer Res. Treat. 68, 45-54 (2001).
59. D.K.W. Yeung, H.S. Cheung, G.M.K. Tse, Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy-Initial Results, Radiology 220, 40-46 (2001).
60. I. Khalkhali, E. Itti, Functional breast imaging using the single photon technique, Nuclear Medicine Communications 23, 609-611 (2002).
61. D.B. Kopans, Breast Imaging, 2nd Edition, Lippincott-Raven Publishers, Philadelphia, 1998.
62. K. Belkić, Magnetic Resonance Spectroscopic Imaging in Breast Cancer Detection: Possibilities Beyond The Conventional Theoretical Framework For Data Analysis. Nucl. Instru. Meth. Phys. Res. A. (in press, May 2004).
63. N.R. Jagannathan, M. Kumar, V. Seenu et al, Evaluation of total Choline from in vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer, Br. J. Cancer 84, 1016-1022 (2001).
64. C. Rosé, J. Dose, N. Avril, Positron emission tomography for the diagnosis of breast cancer, Nuclear Medicine Communications 23, 613-618 (2002).
65. 1H MR spectroscopy, J. Magn. Reson. Imaging 10, 159-164 (1999).
66. I.S. Gribbestad, B. Sitter, S. Lundgren, J. Krane, D. Axelson, Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy, Anticancer Res. 19, 1737-1746 (1999).
67. N.R. Jagannathan, M. Singh, V. Govindaraju et al, Volume localized in vivo proton MR spec-troscopy of breast carcinoma: variation of water-fat ratio in patients receiving chemotherapy, NMR Biomed. 11, 414-422 (1998).
68. P.E. Sijens, H.K. Wijrdeman, M.A. Moerland et al, Human breast cancer in vivo: H-1 and P-31 MR spectroscopy at 1.5 T, Radiology 169, 615-620 (1988).
69. S.K. Mukherji, S. Schiro, M. Castillo et al, Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies, Am. J. Neuroradiol. 18, 1057-1072 (1997).
70. P. Schmitt, M. Kotas, A. Tobermann, A. Haase, M. Flentje, Quantitative tissue perfusion measurements in head and neck carcinoma patients before and during radiation therapy with a non-invasive MR imaging spin-labeling technique, Radiotherapy and Oncology 67, 27-34 (2003).
71. W. Negendank, Studies of human tumours by MRS: A review, NMR Biomed. 5, 303-324 (1992).
72. N.R. Aiken, R.J. Gillies, Phosphomonoester metabolism as a function of cell proliferative status and exogenous precursors, Anticancer Research 16, 1393-1398 (1996).
73. 31P MR spectral alterations in human hepatic tumours, NMR Biomed. 11, 354-359 (1998).
74. K. Kinkel, Y. Ly, M. Both et al, Detection of hepatic metastases from cancers of the gas-trointestinal tract by using non-invasive imaging methods (US, CT, MR imaging, PET): A meta-analysis, Radiology 224, 748-756 (2002).
75. R.M. Dixon, NMR studies of phospholipid metabolism in hepatic hymphoma, NMR Biomed. 11, 370-379 (1998).
76. M. Ljungberg, G. Westberg, B. Vikhoff-Baaz et al, P-31 MRS of liver metastases of neuroen-docrine tumours treated with hepatic artery embolisation, Magnetic Resonance Materials in Physics, Biology and Medicine 15 (Suppl.), 130-131 (2002).
77. J.M. Maris, A.E. Evans, A.C. McLaughlin et al, 31P nuclear magnetic resonance spectroscopic investigation of human neuroblastoma in situ, N. Engl. J. Med. 312, 1500-1505 (1985).
78. J.R. Griffiths, A.R. Tate, F.A. Howe, M. Stubbs, as part of the Multi-Institutional Group on MRS Application to Cancer, Magnetic resonance spectroscopy of cancer - practicalities of multi-centre trials and early results in non-Hodgkin's lymphoma, Eur. J. Cancer 38, 2085-2093 (2002).
79. Dž. Belkić, P.A. Dando, J. Main, H.S. Taylor, Three novel high-resolution nonlinear methods for fast signal processing, J. Chem. Phys. 133, 6542-6556 (2000).
80. H. Gunther, NMR Spectroscopy: Basic principles, concepts and applications in chemistry, 2nd Edition, John Wiley & Sons, Chichester, 2001.
81. Dž. Belkić, Padé-based magnetic resonance spectroscopy (MRS), J. Comp. Meth. Sci. Eng. 3, 563-729 (2003).